The cost-effectiveness of TheraSphere vs. cTACE & DEB-TACE*
Drive more meaningful, personalized patient conversations leveraging HCC cost effectiveness data. Hear Dr. Osman Ahmed and Dr. Mikin Patel discuss increasing patient quality of life instead of simply prolonging it, while also considering how long-term therapy costs can influence treatment decisions. You don’t want to miss this conversation that showcases health economics and therapy options through a more nuanced, patient-focused lens.
*The loading of doxuribicin to LC Beads is outside of the indication for use in the USA.